Revelation BiosciencesREVB
那斯達克 · USD
1.10
+0.01
(+0.92%)
收盤 08/25 03:48 (UTC+8)
08/25 03:48 (UTC+8)
Revelation BiosciencesREVB
1.10
+0.01
(+0.92%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 3,662 | 3,093 | 2,571 | 1,943 | 2,461 | - | 1,754 | - | - | 1,903 |
研發費用 | 1,918 | 1,377 | 964 | 923 | 1,318 | 859 | 606 | 831 | 1,395 | 718 |
推銷及管理費用 | 1,744 | 1,716 | 1,607 | 1,020 | 1,143 | 1,236 | 1,148 | 966 | 1,127 | 1,185 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -3,662 | -3,093 | -2,572 | -1,943 | -2,461 | -2,095 | -1,754 | -1,797 | -2,522 | -1,902 |
其他收入及費用 | 339 | 83 | 61 | 36 | 17 | 44 | 28 | -445 | -5,867 | -779 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -3,323 | -3,009 | -2,511 | -1,907 | -2,444 | -2,051 | -1,726 | -2,242 | -8,390 | -2,681 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -3,323 | -3,009 | -2,511 | -1,907 | -2,444 | -2,051 | -1,726 | -2,242 | -8,390 | -2,681 |
基本每股稅後盈餘(元) | -0.87 | -2.71 | -0.41 | -1.77 | -2.34 | -2.11 | -0.31 | -0.84 | -15.39 | -2.46 |
稀釋每股稅後盈餘(元) | -0.70 | -2.71 | 3.77 | 3.84 | -2.42 | -2.11 | 1.90 | 0.75 | -5.66 | -2.46 |
基本平均股數(千股) | 3829.00 | 3207.00 | 6096.00 | 2644.00 | 2408.00 | 971.00 | 5544.00 | 2679.00 | 545.00 | 1089.00 |
稀釋平均股數(千股) | 3829.00 | 3207.00 | 6096.00 | 2644.00 | 2408.00 | 971.00 | 5544.00 | 2679.00 | 545.00 | 1089.00 |
還原基本每股稅後盈餘(元) | -0.87 | -2.71 | -1.65 | -7.08 | -28.04 | -25.32 | -59.76 | -160.60 | -2955.24 | -472.44 |
還原稀釋每股稅後盈餘(元) | -0.70 | -2.71 | 15.09 | 15.35 | -29.05 | -25.34 | 364.04 | 143.88 | -1087.64 | -472.44 |
還原基本平均股數(千股) | 3,829 | 3,207 | 1,524 | 661 | 200 | 80 | 28 | 13 | 2 | 5 |
還原稀釋平均股數(千股) | 3,829 | 3,207 | 1,524 | 661 | 200 | 80 | 28 | 13 | 2 | 5 |
EBITDA(千元) | -3,315 | -3,002 | -2,505 | -1,900 | -2,437 | -2,044 | -1,719 | -2,235 | -8,383 | -2,675 |